Wall Street succumbs to soaring bond yields

Reuters 

By Medha Singh

The dropped for the first time in six days and, along with the benchmark 500, was on pace for its biggest one-day drop since late June. The Nasdaq fell nearly 2 percent, dragged down by a drop in heavyweight stocks.

Ten of the 11 sectors were lower. The communication services sector sagged 1.4 percent, with and dropping more than 2 percent each, while sliding 1.6 percent.

declined 1.3 percent and were the biggest drag on the markets. fell 1 percent.

The yield on the benchmark 10-year note was perched at seven-year high as strong economic data on Wednesday raised expectations that the non-farm payrolls report due out on Friday morning would come in stronger than anticipated. [US/]

Of particular interest will be the wage growth for September, especially in the light of raising its to $15 earlier this week.

"I will be more interested in the wage growth figure as another surprise to the upside will fuel expectations that will run above the targeted 2 percent and the Fed may need to tighten policy faster than previously projected," said Hussein Sayed, at

The only pocket of growth in the market was the financial sector as the - the spread between two- and 10-year yields - steepened to a two-month high.

jumped 1.2 percent, outstripping the 0.9 percent rise in the overall financial sector.

At 12:01 a.m. EDT the Dow was down 263.60 points, or 0.98 percent, at 26,564.79, the 500 was down 26.99 points, or 0.92 percent, at 2,898.52 and the was down 134.84 points, or 1.68 percent, at 7,890.24.

Despite the pullback, U.S. stocks are trading near record levels, raising concerns about valuations with the earnings season just around the corner.

"Yields are giving the markets a chance to take a breather at very high levels. I think we will have a defensive, bumpy session going into Friday's unemployment data," said Peter Cardillo, at in

Among gainers, shares jumped 3.4 percent after the Corona raised its full-year profit forecast and topped Wall Street's estimates for second-quarter sales and profit.

rose 3.6 percent after the company's experimental diabetes drug showed promise in a mid-stage trial.

Declining issues outnumbered advancers for a 3.80-to-1 ratio on the NYSE. Declining issues outnumbered advancers for a 2.89-to-1 ratio on the Nasdaq.

The S&P index recorded 8 new 52-week highs and 13 new lows, while the Nasdaq recorded 20 new highs and 62 new lows.

(Reporting by in Bengaluru; Editing by Anil D'Silva)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Thu, October 04 2018. 22:04 IST